Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice

BACKGROUND: Although the efficacy of bevacizumab has been established in patients with metastatic colorectal cancer (mCRC), population-based studies are needed to gain insight into the actual implementation of bevacizumab in daily practice. Since these studies are lacking for patients with metachron...

Descripción completa

Detalles Bibliográficos
Autores principales: Razenberg, L. G. E. M., van Gestel, Y. R. B. M., de Hingh, I. H. J. T., Loosveld, O. J. L., Vreugdenhil, G., Beerepoot, L. V., Creemers, G. J., Lemmens, V. E. P. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754889/
https://www.ncbi.nlm.nih.gov/pubmed/26882902
http://dx.doi.org/10.1186/s12885-016-2158-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754889/
https://www.ncbi.nlm.nih.gov/pubmed/26882902
http://dx.doi.org/10.1186/s12885-016-2158-8

Ejemplares similares